Work

703 - Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with moderate and/or more extensive atopic dermatitis: subgroup analysis from the TRuE-AD3 study

Year: 2024

Type: article

Source: British Journal of Dermatology

DOI: 10.1093/bjd/ljae266.077

Authors: Lawrence F Eichenfield, April W Armstrong, Linda F Stein Gold, Andrea L Zaenglein, Lara Wine Lee, Kanwaljit K Brar, Joel C Joyce, Kristen E Holland, Brett Angel, Daniel Sturm, Qian Li, Eric L Simpson

Institutions: University of California San Diego, University of California, Los Angeles, Henry Ford Health, Pennsylvania State University, Penn State Milton S. Hershey Medical Center, Medical University of South Carolina, NYU Langone Health, New York University, Endeavor Health, Medical College of Wisconsin, Incyte (United States), Oregon Health & Science University

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401435992

FWCI:

Cites:

Cited by:

Related to: 10